Deborah Stocken
Impact in
- Oncology top 0.2%
- Pancreatic and Hepatic Oncology Research
- Hepatology top 0.5%
Papers in
- Co-authors
- John P. NeoptolemosJanet DunnD. SpoonerF LacaineMarkus W. BüchlerMassimo FalconiLaureano Fernández‐CruzClaudio Bassi
- Journals
- BMJ Open (12 papers)British Journal of Cancer (10 papers)Trials (9 papers)Journal of Clinical Oncology (8 papers)British Journal of Dermatology (5 papers)
- Partner nations
- United KingdomGermanyUnited States
In The Last Decade
Deborah Stocken
111 papers receiving 9.2k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Oncology 5.2k
- Hepatology 1.0k
- Cancer Research 1.6k
- Epidemiology 3.3k
- Endocrinology, Diabetes and Metabolism 1.4k
Countries citing papers authored by Deborah Stocken
This map shows the geographic impact of Deborah Stocken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Stocken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Stocken more than expected).
Fields of papers citing papers by Deborah Stocken
This network shows the impact of papers produced by Deborah Stocken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Stocken. The network helps show where Deborah Stocken may publish in the future.
Co-authors
The 25 scholars most cited alongside Deborah Stocken, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | Artificial intelligence in digital pathology: a systematic review and meta-analysis of diagnostic test accuracy Hit paper breakdown → | 2024 | 67 |
| 4 | 2024 | 3 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 10 | |
| 7 | 2022 | 17 | |
| 8 | 2022 | 6 | |
| 9 | 2021 | 1 | |
| 10 | 2020 | 2 | |
| 11 | 2020 | 19 | |
| 12 | 2019 | 28 | |
| 13 | 2018 | 20 | |
| 14 | 2018 | 5 | |
| 15 | 2017 | 14 | |
| 16 | 2015 | 27 | |
| 17 | 2013 | 146 | |
| 18 | 2013 | 39 | |
| 19 | 2004 | 397 | |
| 20 | Meta-analysis of adjuvant chemoradiotherapy and chemotherapy for resectable pancreatic cancer including the final results of the ESPAC-1 trial | 1998 | 2 |
About Deborah Stocken
Deborah Stocken is a scholar working on Oncology, Surgery, Statistics and Probability, Otorhinolaryngology and Hepatology, having authored 118 papers that have together received 9.4k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (25 papers), Pancreatitis Pathology and Treatment (15 papers), Neuroendocrine Tumor Research Advances (12 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers), Statistical Methods in Clinical Trials (8 papers), Renal cell carcinoma treatment (6 papers), Cardiac, Anesthesia and Surgical Outcomes (6 papers) and Liver Disease Diagnosis and Treatment (6 papers). The work is most often cited by research in Oncology (5.2k citations), Hepatology (1.0k citations), Cancer Research (1.6k citations), Epidemiology (3.3k citations) and Endocrinology, Diabetes and Metabolism (1.4k citations). Deborah Stocken has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include John P. Neoptolemos, Janet Dunn, D. Spooner, F Lacaine, Markus W. Büchler, Massimo Falconi, Laureano Fernández‐Cruz, Claudio Bassi, Christos Dervenis and Helen Hickey. Their work appears in journals such as BMJ Open, British Journal of Cancer, Trials, Journal of Clinical Oncology and British Journal of Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.